Loading organizations...
§ Private Profile · Menlo Park, CA, USA
Develops & manufactures injectable drug delivery devices, safety syringes for needlestick prevention, for pharma & biotech.
Founded in 2011 by Jeff Shanley and Frank Litvack through the Reprise Medical incubator, Credence MedSystems is a Menlo Park, California-based company developing injectable drug delivery devices for pharmaceutical and biotechnology customers. Led by executives including Chief Commercial Officer John Merhige and board member Benjamin Hall, the enterprise operates with fewer than 25 employees while generating $5.4 million in annual revenue. Across seven distinct financing rounds, the business has secured $76 million in total funding, highlighted by a recent $39.9 million capital injection. The manufacturer specializes in fully passive safety syringes and auto-sensing injection systems, prominently featuring the Companion Safety Syringe System and the Credence Connect Auto-Sensing Injection System. Following a philosophy of innovation without change, these products provide needlestick prevention and auto-disabling capabilities without requiring alterations to the existing pharmaceutical manufacturing supply chain.
Credence MedSystems has raised $67.7M across 3 funding rounds.
Credence MedSystems has raised $67.7M in total across 3 funding rounds.
Credence MedSystems has raised $67.7M across 3 funding rounds. Most recently, it raised $39.9M Other Equity in September 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 22, 2021 | $39.9M Venture Round | — | Molex Ventures, Novartis Pharma | Announced |
| Aug 7, 2018 | $12.8M Series B | — | — | Announced |
| Sep 13, 2016 | $15M Series A | — | — | Announced |
Credence MedSystems has raised $67.7M in total across 3 funding rounds.
Credence MedSystems's investors include Molex Ventures, Novartis Pharma.